Literature DB >> 7715297

Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome.

S Aono1, Y Adachi, E Uyama, Y Yamada, H Keino, T Nanno, O Koiwai, H Sato.   

Abstract

Gilbert's and Crigler-Najjar syndromes are characterised by unconjugated hyperbilirubinaemia due to complete and partial absence of bilirubin UDP-glucuronosyltransferase (UGT). Nucleotide sequences of the genes for bilirubin UGT were analysed in six patients with Gilbert's syndrome. All patients had a missense mutation caused by a single nucleotide substitution and the mutations were heterozygous. In addition, relatives of patients with Crigler-Najjar syndrome types I and II, and of those with Gilbert's syndrome were analysed. All ten relatives with mild hyperbilirubinaemia were heterozygotes with respect to each defective allele. These results suggest that Gilbert's syndrome is inherited as a dominant trait.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7715297     DOI: 10.1016/s0140-6736(95)90702-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  26 in total

Review 1.  Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy.

Authors:  Jacqueline Ramírez; Mark J Ratain; Federico Innocenti
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

2.  Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.

Authors:  Shabana Farheen; Sanghamitra Sengupta; Amal Santra; Suparna Pal; Gopal Krishna Dhali; Meenakshi Chakravorty; Partha P Majumder; Abhijit Chowdhury
Journal:  World J Gastroenterol       Date:  2006-04-14       Impact factor: 5.742

3.  Molecular analysis of patients of Sardinian descent with Crigler-Najjar syndrome type I.

Authors:  M C Rosatelli; A Meloni; V Faa; L Saba; G Crisponi; M G Clemente; G Meloni; M T Piga; A Cao
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

Review 4.  Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years.

Authors:  Mariusz Panczyk
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

5.  Prediction of deleterious non-synonymous single-nucleotide polymorphisms of human uridine diphosphate glucuronosyltransferase genes.

Authors:  Yuan Ming Di; Eli Chan; Ming Qian Wei; Jun-Ping Liu; Shu-Feng Zhou
Journal:  AAPS J       Date:  2009-07-02       Impact factor: 4.009

Review 6.  Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

Authors:  João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Mol Neurobiol       Date:  2009-04-17       Impact factor: 5.590

7.  Transcriptional regulation of human UGT1A1 gene expression through distal and proximal promoter motifs: implication of defects in the UGT1A1 gene promoter.

Authors:  Junko Sugatani; Kousuke Mizushima; Makoto Osabe; Kasumi Yamakawa; Satoru Kakizaki; Hitoshi Takagi; Masatomo Mori; Akira Ikari; Masao Miwa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-03       Impact factor: 3.000

8.  Association of UGT1A1 variants and hyperbilirubinemia in breast-fed full-term Chinese infants.

Authors:  Youyou Zhou; San-nan Wang; Hong Li; Weifeng Zha; Xuli Wang; Yuanyuan Liu; Jian Sun; Qianqian Peng; Shilin Li; Ying Chen; Li Jin
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

9.  Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

Authors:  E Beutler; T Gelbart; A Demina
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

10.  Rapid allelic discrimination by TaqMan PCR for the detection of the Gilbert's syndrome marker UGT1A1*28.

Authors:  Ursula Ehmer; Tim O Lankisch; Thomas J Erichsen; Sandra Kalthoff; Nicole Freiberg; Michael Wehmeier; Michael P Manns; Christian P Strassburg
Journal:  J Mol Diagn       Date:  2008-10-02       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.